Intravenous Equipment Market by Contact Position, End User

List of Tables

The Intravenous Equipment Market is projected to reach USD 18.93 billion by 2030 from USD 11.89 billion in 2022, at a CAGR of 5.98% during the forecast period.

Global Intravenous Equipment Market

KEY MARKET STATISTICS
Base Year Value [2022]	USD 11.89 billion
Estimated Year Value [2023]	USD 12.54 billion
Forecast Year Value [2030]	USD 18.93 billion
CAGR (%)	5.98%

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Intravenous Equipment Market.

Based on Contact Position, market is studied across Administration Sets, Drip Chambers, Infusion Pumps, IV Catheters, Needleless Connectors, Securement Devices, and Stopcocks & Check Valves. The Administration Sets is further studied across Blood Administration Sets and Solution Administration Sets. The Infusion Pumps is projected to witness significant market share during forecast period.

Based on End User, market is studied across Ambulatory Care Centers, Home Care, and Hospitals & Clinics. The Home Care is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Asia-Pacific is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Intravenous Equipment Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Intravenous Equipment Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Intravenous Equipment Market, highlighting leading vendors and their innovative profiles. These include Abcam Inc., Advin Health Care, Angel Electronic Equipment Co., Ltd., Argon Medical Devices, Inc., B. Braun SE, Baxter International, Inc., Becton, Dickinson and Company, Boston Scientific Corporation, Cardinal Health, Inc., CODAN ARGUS AG, Cook Group Incorporated, Freudenberg Medical, LLC, Henry Schein, Inc., ICU Medical, Inc, Ivenix Inc., Merck KGaA, Novo Nordisk A/S, Pfizer Inc., QIAGEN, Siemens AG, Smith & Nephew PLC, Stryker Corporation, Teleflex Incorporated., Terumo Corporation, and Thermo Fisher Scientific Inc..

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.

2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.

3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.

4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.

5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the Intravenous Equipment Market?

2. Which products, segments, applications, and areas hold the highest investment potential in the Intravenous Equipment Market?

3. What is the competitive strategic window for identifying opportunities in the Intravenous Equipment Market?

4. What are the latest technology trends and regulatory frameworks in the Intravenous Equipment Market?

5. What is the market share of the leading vendors in the Intravenous Equipment Market?

6. Which modes and strategic moves are suitable for entering the Intravenous Equipment Market?

Product Code: MRR-F6513A06BF15

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Intravenous Equipment Market, by Region

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing prevalence of chronic diseases worldwide
  - 5.1.1.2. Inclination toward early diagnosis and treatment of diseases
  - 5.1.1.3. Growing trend towards home healthcare
- 5.1.2. Restraints
  - 5.1.2.1. High cost and stringent regulatory framework
- 5.1.3. Opportunities
  - 5.1.3.1. Advancements and improvements in intravenous equipment
  - 5.1.3.2. Emerging trend of telemedicine platforms
- 5.1.4. Challenges
  - 5.1.4.1. Limited skilled professionals and product safety concerns
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Intravenous Equipment Market, by Contact Position

6.1. Introduction
6.2. Administration Sets
- 6.3.1. Blood Administration Sets
- 6.3.2. Solution Administration Sets
6.3. Drip Chambers
6.4. Infusion Pumps
6.5. IV Catheters
6.6. Needleless Connectors
6.7. Securement Devices
6.8. Stopcocks & Check Valves

7. Intravenous Equipment Market, by End User

7.1. Introduction
7.2. Ambulatory Care Centers
7.3. Home Care
7.4. Hospitals & Clinics

8. Americas Intravenous Equipment Market

8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Intravenous Equipment Market

9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Intravenous Equipment Market

10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape

11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

12.1. Key Company Profiles
- 12.1.1. Abcam Inc.
- 12.1.2. Advin Health Care
- 12.1.3. Angel Electronic Equipment Co., Ltd.
- 12.1.4. Argon Medical Devices, Inc.
- 12.1.5. B. Braun SE
- 12.1.6. Baxter International, Inc.
- 12.1.7. Becton, Dickinson and Company
- 12.1.8. Boston Scientific Corporation
- 12.1.9. Cardinal Health, Inc.
- 12.1.10. CODAN ARGUS AG
- 12.1.11. Cook Group Incorporated
- 12.1.12. Freudenberg Medical, LLC
- 12.1.13. Henry Schein, Inc.
- 12.1.14. ICU Medical, Inc
- 12.1.15. Ivenix Inc.
- 12.1.16. Merck KGaA
- 12.1.17. Novo Nordisk A/S
- 12.1.18. Pfizer Inc.
- 12.1.19. QIAGEN
- 12.1.20. Siemens AG
- 12.1.21. Smith & Nephew PLC
- 12.1.22. Stryker Corporation
- 12.1.23. Teleflex Incorporated.
- 12.1.24. Terumo Corporation
- 12.1.25. Thermo Fisher Scientific Inc.
12.2. Key Product Portfolio

13. Appendix

13.1. Discussion Guide
13.2. License & Pricing